| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/20/2013 | CN103402532A Enteral nutrient |
| 11/20/2013 | CN103402531A Multivalent synthetic compounds as antibiotic treatment |
| 11/20/2013 | CN103402527A Compositions and methods for cell transplantation |
| 11/20/2013 | CN103397013A Medicine composition pancreatin enteric capsule and preparation method thereof |
| 11/20/2013 | CN103397012A Novel asparaginase enzyme variants and uses thereof |
| 11/20/2013 | CN103397011A Recombinant or transgenic factor VII compound having a majority of glycan, biantennary, bisialylated and non-fucosylated forms |
| 11/20/2013 | CN103397009A Improved-type human coagulation factor FVII-Fc fusion protein as well as preparation method and application thereof |
| 11/20/2013 | CN103396998A Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression |
| 11/20/2013 | CN103396545A Polymer, glucose-sensitive nanogel, glucose-sensitive drug loading nanogel and preparation methods thereof |
| 11/20/2013 | CN103396478A Recombinant N-glycosylated protein from procaryotic cell |
| 11/20/2013 | CN103396476A Two cyclic hexapeptide compounds and application thereof in preparation of antibacterial drug |
| 11/20/2013 | CN103396474A APJ receptor compound |
| 11/20/2013 | CN103396473A Cxcr4 receptor compound |
| 11/20/2013 | CN103396472A Scorpion extract with thrombolytic activity |
| 11/20/2013 | CN103396471A Metal beta-lactamase inhibitory peptide and application thereof |
| 11/20/2013 | CN103394098A Application of expression vector of natural killer cell enhancement factor (NKEF) of turbot |
| 11/20/2013 | CN103394083A Monomethylvaline compounds capable of conjugation to ligands |
| 11/20/2013 | CN103394078A Self-pressurized multi-target collaborative hemostasis degradable hemostatic preparation for injury first aid |
| 11/20/2013 | CN103394077A Eye drop |
| 11/20/2013 | CN103394076A Process for preparing human serum albumin |
| 11/20/2013 | CN103394075A Application of PHA-L (Phaseolus vulgaris-Leucoagglutinin) phytolectin in radio-resistive effect and pharmaceutical composition preparation taking PHA-L as main active component |
| 11/20/2013 | CN103394074A Cyclic antimicrobial peptides |
| 11/20/2013 | CN103394073A Application of perilipin in preparation of medicine |
| 11/20/2013 | CN103394072A Paste for treating nucleus of fresh-water nuclear pearl, and preparation method and application thereof |
| 11/20/2013 | CN103394071A Method for producing giant salamander polypeptide powder liver protection capsules |
| 11/20/2013 | CN103393731A Mercury expelling agent |
| 11/20/2013 | CN103393630A Method of inducing terminal differentiation |
| 11/20/2013 | CN103393104A Preparation method of samara oil pulverized tablet |
| 11/20/2013 | CN102757478B Allyl cysteinyl amino acid derivative and synthesis method and application thereof |
| 11/20/2013 | CN102671189B Iron protein succinylate solubilizing method and oral solution preparation thereof |
| 11/20/2013 | CN102628073B Glycosylated lactalbumin polypeptide with antioxidant activity as well as preparation method and application of glycosylated lactalbumin polypeptide |
| 11/20/2013 | CN102584980B Interferon alpha mutant and polyethylene glycol derivative thereof |
| 11/20/2013 | CN102382806B TAT-WNK102 transmembrane protein and application thereof |
| 11/20/2013 | CN102366627B Protein sensitizer of tumor chemotherapeutics |
| 11/20/2013 | CN102363633B Glucagon like peptide-1 mutant polypeptide and preparation method, medicinal composition and use thereof |
| 11/20/2013 | CN102329246B Multiple-target-point tamibarotene derivatives, preparation method and purposes thereof |
| 11/20/2013 | CN102294022B SOD (superoxide dismutase) preparation and preparation method thereof |
| 11/20/2013 | CN102260352B Targeted interleukin fusion protein as well as preparation method thereof and application thereof |
| 11/20/2013 | CN101951939B Pegylation by the dock and lock (DNL) technique |
| 11/20/2013 | CN101896193B An agent for reducing a side effect of an anticancer drug |
| 11/20/2013 | CN101888851B Methods for treatment of stroke or cerebrovascular accidents using an etb receptor agonist |
| 11/20/2013 | CN101812126B Novel HLA-A2 restrictive epitope polypeptide coming from hPEBP4 protein and application thereof |
| 11/20/2013 | CN101759775B Leech active small peptide and preparation method and application thereof |
| 11/20/2013 | CN101703761B Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 11/20/2013 | CN101648996B Anti-myocardial remodelling polypeptide, preparation method thereof, preparations and application thereof in preparation of anti-myocardial remodelling medicament |
| 11/20/2013 | CN101444621B Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (FGE) |
| 11/20/2013 | CN101367872B Protein-polymer conjugates |
| 11/19/2013 | US8586744 Antiviral phosphinate compounds |
| 11/19/2013 | US8586717 Method for the diagnosis and prognosis of malignant diseases |
| 11/19/2013 | US8586710 Process for gram scale production of PEG-r-metHuG-CSF |
| 11/19/2013 | US8586707 Stapled peptides and method of synthesis |
| 11/19/2013 | US8586706 Peptide vaccine using mimic molecules of amyloid β peptide |
| 11/19/2013 | US8586705 Macromolecular compounds having controlled stoichiometry |
| 11/19/2013 | US8586681 Multi-arm block copolymers as drug delivery vehicles |
| 11/19/2013 | US8586633 Ophthalmologic irrigation solutions and method |
| 11/19/2013 | US8586570 Sox-based kinase sensor |
| 11/19/2013 | US8586548 NAP alpha-aminoisobutyric acid analog with neuroprotective activity |
| 11/19/2013 | US8586547 CDC45L peptides and vaccines including the same |
| 11/19/2013 | US8586546 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors |
| 11/19/2013 | US8586545 Solid materials of {[(2S, 5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acid} and methods for obtaining them |
| 11/19/2013 | US8586543 IL-8 biomarker for monitoring cancer treatment with certain ERK inhibitors |
| 11/19/2013 | US8586542 Small molecule apoptosis promoters |
| 11/19/2013 | US8586540 Composition for improving skin conditions using fetal mesenchymal stem cells from amniotic fluid |
| 11/19/2013 | US8586539 Beta sheet tapes ribbons in tissue engineering |
| 11/19/2013 | US8586538 Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII |
| 11/19/2013 | US8586537 Method for treating minor aphthous ulcers |
| 11/19/2013 | US8586535 Humanized recombinant uricase and mutants thereof |
| 11/19/2013 | US8586534 Intracellular domain of a mammalian Fat1 (Fat1IC) |
| 11/19/2013 | US8586533 Treatment of early-stage osteoarthritis |
| 11/19/2013 | US8586532 Method for selectively modifying a protein via transglutaminase catalyzed reaction |
| 11/19/2013 | US8586531 Erythropoietin immunoglobulin fusion proteins |
| 11/19/2013 | US8586529 Composition for preventing and improving metabolic syndrome |
| 11/19/2013 | US8586528 Biologically active peptides and their new uses |
| 11/19/2013 | US8586526 DNA-binding proteins and uses thereof |
| 11/19/2013 | US8586525 Biologically active peptides and their new uses |
| 11/19/2013 | US8586524 Modulators of pharmacological agents |
| 11/19/2013 | US8586345 Electroprocessed collagen and tissue engineering |
| 11/19/2013 | US8586330 Methods for producing secreted polypeptides having biological activity |
| 11/19/2013 | US8586325 Enzyme substrate comprising a functional dye and associated technology and methods |
| 11/19/2013 | US8586319 Recombinant ACE2 polypeptide dimer |
| 11/19/2013 | US8586317 Methods of diagnosing hypophosphatemic disorders |
| 11/19/2013 | US8586298 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
| 11/19/2013 | US8586291 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571 |
| 11/19/2013 | US8586107 Schisandra sphenanthera fruit extract and cosmetic, dermatological, and nutraceutical compositions comprising same |
| 11/19/2013 | US8586088 Tamper-resistant oral opioid agonist formulations |
| 11/19/2013 | US8586077 Nutritional composition for infants |
| 11/19/2013 | US8586070 Composition and device for treating bone and/or cartilage defects |
| 11/19/2013 | US8586061 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement |
| 11/19/2013 | US8586054 Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists |
| 11/19/2013 | US8586048 G-CSF immunoglobulin fusion proteins |
| 11/19/2013 | US8586039 Degraded TPO agonist antibody |
| 11/19/2013 | US8586036 Methods for the treatment of IL-1β related diseases |
| 11/19/2013 | US8586034 Cytomegalovirus disintegrin-like peptides |
| 11/19/2013 | US8586032 Use of alkaline phosphatase in the treatment of reduced renal function |
| 11/19/2013 | US8586031 Method of reusing rinse water from disinfecting packages with peracid and catalase |
| 11/19/2013 | US8586030 Co-enzyme Q10 formulations and methods of use |
| 11/19/2013 | CA2613976C New pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers |
| 11/19/2013 | CA2593520C Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 11/19/2013 | CA2569191C C-met kinase binding proteins |
| 11/19/2013 | CA2528375C Macrocyclic antagonists of the motilin receptor |